By Dr John James Moore

Journal articles

Moore JJ; Ma DD; Will R; Cannell P; Handel ML; Milliken ST, 2004, 'A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation', Bone Marrow Transplantation, 34, pp. 241 - 247, http://www.sciencedirect.com/science/article/B6WVB-4CX0S62-K6/2/82576fabf01404bdf5cb9daf484bfd5d

Snowden J; Passweg J; Moore JJ; Milliken ST; Cannell P; Van Laar J; Verburg R; Szer J; Taylor KM; Joske D; Rule S; Bingham S; Emery P; Burt R; Lowenthal RM; Durez P; McKendry R; Pavletic S; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks PM; Bredeson C; Tyndall A, 2004, 'Autologous hemopoietic stem cell transplantation in severe rheumatoidarthritis: A report from the EBMT and ABMTR', Journal of Rheumatology, 31, pp. 482 - 488

Zaunders J; Dyer W; Wang B; Munier M; Miranda-Saksena M; Newton R; Moore JJ; MacKay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, 8, pp. 2765 - 2765

Moore JJ; Ma DD; Dodds T; Milliken ST; Fay K; Concannon A; smith I, 2004, 'Improved disease survival without increased GVHD using low dose cyclosporine and prednisone in allogeneic stem cell transplantation - A case control study', Blood, 104, pp. 371B - 371B

Bingham S; Moore JJ, 2004, 'Rheumatoid arthritis', Best Practice and Research Clinical Haematology, 17, pp. 263 - 276, http://www.sciencedirect.com/science/article/B6WBG-4D1TPYX-7/2/eb0d083ddca8cebd0b3fee780a2cd458

Moore JJ; Johnston AM; David M; Sam MJ; Keith F; Tony D, 2004, 'Treatment of steroid-refractory acute graft versus host disease with low dose combination monoclonal antibody therapy: A pilot study', Blood, 104, pp. 354A - 354A

Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al - Reply', ARTHRITIS AND RHEUMATISM, 48, pp. 1464 - 1466, http://dx.doi.org/10.1002/art.11071

Van Laar JM; Pavletic SZ; Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al [4] (multiple letters)', Arthritis and Rheumatism, 48, pp. 1463 - 1464, http://dx.doi.org/10.1002/art.10982

Moore JJ; Snowden J; Pavletic S; Barr W; Burt R, 2003, 'Hematopoietic stem cell transplantation for severe rheumatoid arthritis', Bone Marrow Transplantation, 32, pp. 53 - 56

Ponchel F; Papadaki H; Bingham S; Verburg R; Moore JJ; Protheroe A; McGonagle D; Snowden J; Van-Laar J; Markham A; Emery P; Isaacs D, 2003, 'Il-7 and therapy-induced lymphopenia in RA', Annals of the Rheumatic Diseases, 62, pp. 164 - 164

Moore JJ; Milliken ST; Ma DD; Biggs JC, 2003, 'Letter to the Editor CD34 selected versus unmanipulated grafts for severe rheumatoid arthritis: Reply', Arthritis Care & Research, 48, pp. 1464 - 1466

Brooks P; Moore JJ; Tyndall A, 2003, 'Stem cell transplantation in rheumatic diseases', Journal of Rheumatology, 6, pp. 79 - 82

Moore JJ; Brooks P; Milliken ST; Biggs JC; Ma DD; Handel ML; Will R; Rule S; Joske D; Langlands B; Taylor K; O Callaghan J; Szer J; Wicks I; McColl GJ; Passeullo F; Snowden J, 2002, 'A pilot randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplanation for severe resistant rheumatoid arthritis', Arthritis Care & Research, 46, pp. 2301 - 2309

Brooks P; Moore JJ; Tyndall A, 2002, 'A stem cell transplantation and gene therapy in Rheumatoid diseases', Annals of the Rheumatic Diseases

Moore J; Brooks P, 2001, 'Stem cell transplantation for autoimmune diseases', Springer Seminars in Immunopathology, 23, pp. 193 - 213, http://dx.doi.org/10.1007/s002810100059

Moore JJ; Brooks P, 2001, 'Haemopoietic stem cell transplantation', Springer Seminars in Immunopathology, pp. 193 - 213

Solomon B; Moore JJ; Arthur C; Prince HM, 2001, 'Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicentre randomised comparison of urokinase versus heparin', European Journal of Cancer, pp. 2379 - 2384

Moore JJ; Milliken ST; Ma DD; Briggs JW; Brooks P, 2001, 'Peripheral blood stem cell transplantation for rheumatoid arthritis - Australian experience', Journal of Rheumatology, 28, pp. 8 - 12

Moore JJ; Tyndall A; Brooks P, 2001, 'Stem cells in the aetiopathogenisis and therapy of rheumatic disease.', Best Practice and Research in Clinical Rheumatology, 15, pp. 711 - 726

Moore J; Aboud M; Ma D, 2000, 'Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile', Thrombosis and Haemostasis, 84, pp. 735 - 736, http://dx.doi.org/10.1055/s-0037-1614103

Moore J; Coyle L; Isbister J; Roche J, 1999, 'Bilateral knee osteonecrosis in a patient with thrombotic thrombocytopenic purpura', Australian and New Zealand Journal of Medicine, 29, pp. 88 - 89, http://dx.doi.org/10.1111/j.1445-5994.1999.tb01596.x

Moore JJ; Isbister JP; Clifton-Bligh P; Eckstein RP, 1998, 'Calcitriol mediated hypercalcaemia in a T cell rich B cell lymphoma [10]', Australian and New Zealand Journal of Medicine, 28, pp. 479 - 480, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02091.x

Moore J; Ma DDF; Concannon A, 1998, 'Non-malignant bone marrow necrosis: A report of two cases', Pathology, 30, pp. 316 - 318, http://dx.doi.org/10.1080/00313029800169526

Moore J; Ma DD; Concannon A, 1998, 'Non-malignant bone marrow necrosis: a report of two cases.', Pathology, 30, pp. 318 - 320, http://dx.doi.org/10.1080/00313029800169536

Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S, 1995, 'Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.', The cancer journal from Scientific American, 1, pp. 252 - 260

Back to profile page